Both UTI and TM treatment alone reduced the serum content of IL-6, IL-1β, TNF-α and NO, and UTI combined with TM further reduced the levels of IL-6 (Figure 6(a)), IL-1β (Figure 6(b)), TNF-α (Figure 6(c)) and NO (Figure 6(d)) induced by LPS. The gene discussed is IL1B; the disease is bacterial urinary tract infection.